BioWorld MedTech

March 20, 2014

View Archived Issues

Washington Roundup: NHLBI eyes TGF-beta as culprit in failure of saphenous vein graft

Court Report: Biolitec CEO a no-show in court, must pay $74.9M to AngioDynamics

HIT Roundup: Health Level introduces software solution for cardiology centers

Financings roundup: Augmedix gets venture funds to expand technology team

Product briefs

People in Places

MDD's Orthopedic Extra

Move could help quell chaotic market: China prepares to crack down on host of device rule breakers

Chinese authorities are taking action to tackle illegal sales and marketing activities in the medical devices as they work to consolidate a market that remains chaotic. Read More

The MDD Interview: Esaote seeks growth by expanding portfolio, markets

Today's news in brief

BioWorld

BioWorld briefs for May 22, 2026.

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

WHO declares Ebola outbreak a public health emergency of international concern

BioWorld

The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...

Nxera Pharma prepares and tests new GPR17 antagonists

BioWorld Science

Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...